While this mild inflammation is not likely significant enough to limit the efficacy of IL-10 in the treatment of uveitis, the high concentration of IL-10 found in the AH and VH and the presence of clinical inflammation supports the need for evaluation of lower doses of IVT AAV-eqIL-10 for the treatment of recurrent uveitis in horses. The gene discussed is IL10; the disease is uveitis.